ADVFN ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Oxford Instruments Delivers Record Annual Revenue and Divests Quantum Unit to Sharpen Focus

Fiona Craig
Market News
13 June 2025 9:22AM

Oxford Instruments plc (LSE:OXIG) has reported impressive full-year results for FY2024/25, surpassing the £500 million revenue milestone for the first time. The performance was fueled by strong demand in its core semiconductor and materials analysis divisions, underscoring the company’s successful strategic direction.

Strategic Quantum Exit and Shareholder Returns

As part of a strategic portfolio realignment, Oxford Instruments announced the divestiture of its NanoScience quantum business in a £60 million transaction. The move enables the company to double down on high-growth opportunities, while unlocking capital for a £50 million share buyback program—an initiative designed to deliver enhanced value to shareholders and support its medium-term operating margin objectives.

Financial and Market Outlook

Backed by consistent top-line expansion and solid profitability, Oxford Instruments remains in a strong financial position. Nevertheless, technical indicators suggest some short-term market caution, despite the company’s reasonable valuation and sound fundamentals. The announced share buyback is expected to support investor sentiment amid broader market uncertainty.

About Oxford Instruments

Founded in 1959 as a University of Oxford spin-out, Oxford Instruments has grown into a global FTSE250 technology leader. The company designs and manufactures advanced tools and systems used in research and industry, serving sectors such as semiconductors, materials science, and life sciences. Its commitment to innovation and scientific excellence continues to underpin its reputation as a trusted partner in cutting-edge applications across academia and commercial enterprise.